C5AR1 and epilepsy: In Rasmussen syndrome, CSF studies demonstrate elevated iC3b, C5a, and soluble MAC, and implicate inadequate MAC control (CD59) in worse seizure profiles, strengthening the human link between complement activation and severe epilepsy.